Parasitology Research

, Volume 110, Issue 6, pp 2475–2480 | Cite as

Effects of symptomatic and asymptomatic isolates of Blastocystis hominis on colorectal cancer cell line, HCT116

  • Kok Hoe Chan
  • Samudi Chandramathi
  • Kumar SureshEmail author
  • Kek Heng Chua
  • Umah Rani Kuppusamy
Original Paper


The pathogenesis of Blastocystis hominis in human hosts has always been a matter of debate as it is present in both symptomatic and asymptomatic individuals. A recent report showed that B. hominis isolated from an asymptomatic individual could facilitate the proliferation and growth of existing cancer cells while having the potential to downregulate the host immune response. The present study investigated the differences between the effects of symptomatic and asymptomatic derived solubilized antigen of B. hominis (Blasto-Ag) on the cell viability and proliferation of colorectal cancer cells. Besides that, the gene expression of cytokine and nuclear transcriptional factors in response to the symptomatic and asymptomatic B. hominis antigen in HCT116 was also compared. In the current study, an increase in cell proliferation was observed in HCT116 cells which led to the speculation that B. hominis infection could facilitate the growth of colorectal cancer cells. In addition, a more significant upregulation of Th2 cytokines observed in HCT116 may lead to the postulation that symptomatic Blasto-Ag may have the potential in weakening the cellular immune response, allowing the progression of existing tumor cells. The upregulation of nuclear factor kappa light chain enhancer of activated B cells (NF-κB) was observed in HCT116 exposed to symptomatic Blasto-Ag, while asymptomatic Blasto-Ag exhibited an insignificant effect on NF-κB gene expression in HCT116. HCT116 cells exposed to symptomatic and asymptomatic Blasto-Ag caused a significant upregulation of CTSB which lead to the postulation that the Blasto-Ag may enhance the invasive and metastasis properties of colorectal cancer. In conclusion, antigen isolated from a symptomatic individual is more pathogenic as compared to asymptomatic isolates as it caused a more extensive inflammatory reaction as well as more enhanced proliferation of cancer cells.


HCT116 Cell Colorectal Cancer Cell Colorectal Cancer Cell Line Solubilized Antigen Colorectal Carcinoma Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The study was funded by University Malaya High Impact Grant UM.C/625/1/HIR and FP070/2010B (Fundamental Research Grant).


  1. Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF, Emmert-Buck MR (1994) Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol 145(2):301–309PubMedGoogle Scholar
  2. Cavallo-Medved D, Dosescu J, Linebaugh BE, Sameni M, Rudy D, Sloane BF (2003) Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells. Neoplasia 5(6):507–519PubMedGoogle Scholar
  3. Chandramathi S, Suresh K, Anita ZB, Kuppusamy UR (2009) Elevated levels of urinary hydrogen peroxide, advanced oxidative protein product (AOPP) and malondialdehyde in humans infected with intestinal parasites. Parasitology 136(3):359–363. doi: 10.1017/S0031182008005465 PubMedCrossRefGoogle Scholar
  4. Chandramathi S, Suresh K, Kuppusamy UR (2010) Solubilized antigen of Blastocystis hominis facilitates the growth of human colorectal cancer cells, HCT116. Parasitol Res 106(4):941–945. doi: 10.1007/s00436-010-1764-7 PubMedCrossRefGoogle Scholar
  5. Daugelat S, Kaufmann SH (1996) Role of Th1 and Th2 cells in bacterial infections. Chem Immunol 63:66–97PubMedCrossRefGoogle Scholar
  6. Fitzpatrick FA (2001) Inflammation, carcinogenesis and cancer. Int Immunopharmacol 1(9–10):1651–1667PubMedCrossRefGoogle Scholar
  7. Garcia LS (2007) Diagnostic medical parasitology, 5th edn. ASM Press, Washington, pp 27–32Google Scholar
  8. Hart J (2002) Inflammation. 1: its role in the healing of acute wounds. J Wound Care 11(6):205–209PubMedGoogle Scholar
  9. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75(2):263–274PubMedCrossRefGoogle Scholar
  10. Lanuza MD, Carbajal JA, Villar J, Borras R (1997) Description of an improved method for Blastocystis hominis culture and axenization. Parasitol Res 83(1):60–63PubMedCrossRefGoogle Scholar
  11. Ley K (2001) Pathways and bottlenecks in the web of inflammatory adhesion molecules and chemoattractants. Immunol Res 24(1):87–95. doi: 10.1385/IR:24:1:87 PubMedCrossRefGoogle Scholar
  12. Long HY, Handschack A, Konig W, Ambrosch A (2001) Blastocystis hominis modulates immune responses and cytokine release in colonic epithelial cells. Parasitol Res 87(12):1029–1030PubMedGoogle Scholar
  13. Ludewig B, Zinkernagel RM, Hengartner H (2002) Arterial inflammation and atherosclerosis. Trends Cardiovasc Med 12(4):154–159PubMedCrossRefGoogle Scholar
  14. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63PubMedCrossRefGoogle Scholar
  15. Perry G, Castellani RJ, Hirai K, Smith MA (1998) Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimer’s Dis: JAD 1(1):45–55Google Scholar
  16. Puthia MK, Lu J, Tan KS (2008) Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-kappaB-dependent manner. Eukaryot Cell 7(3):435–443. doi: 10.1128/EC.00371-07 PubMedCrossRefGoogle Scholar
  17. Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE (1995) Free radicals and phagocytic cells. ASEB J Off Pub Fed Am Soc Exp Biol 9(2):200–209Google Scholar
  18. Shacter E, Weitzman SA (2002) Chronic inflammation and cancer. Oncology (Williston Park) 16(2):217–226, 229; discussion 230–212Google Scholar
  19. Stenzel DJ, Boreham PF (1996) Blastocystis hominis revisited. Clin Microbiol Rev 9(4):563–584PubMedGoogle Scholar
  20. Suresh K, Smith H (2004) Comparison of methods for detecting Blastocystis hominis. Eur J Clin Microbiol Infect Dis: Off Pub Eur Soc Clin Microbiol 23(6):509–511. doi: 10.1007/s10096-004-1123-7 CrossRefGoogle Scholar
  21. Suresh K, Venilla GD, Tan TC, Rohela M (2009) In vivo encystation of Blastocystis hominis. Parasitol Res 104(6):1373–1380. doi: 10.1007/s00436-009-1340-1 PubMedCrossRefGoogle Scholar
  22. Tan KS, Singh M, Yap EH (2002) Recent advances in Blastocystis hominis research: hot spots in terra incognita. Int J Parasitol 32(7):789–804PubMedCrossRefGoogle Scholar
  23. Windsor JJ, Macfarlane L, Hughes-Thapa G, Jones SK, Whiteside TM (2002) Incidence of Blastocystis hominis in faecal samples submitted for routine microbiological analysis. Br J Biomed Sci 59(3):154–157PubMedGoogle Scholar
  24. Wong KH, Ng GC, Lin RT, Yoshikawa H, Taylor MB, Tan KS (2008) Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore. Parasitol Res 102(4):663–670. doi: 10.1007/s00436-007-0808-0 PubMedCrossRefGoogle Scholar
  25. Yan S, Sameni M, Sloane BF (1998) Cathepsin B and human tumor progression. Biol Chem 379(2):113–123PubMedGoogle Scholar
  26. Zaman V, Khan KZ (1994) A concentration technique for obtaining viable cysts of Blastocystis hominis from faeces. JPMA J Pak Med Assoc 44(9):220–221PubMedGoogle Scholar
  27. Zaman V, Zaki M (1996) Resistance of Blastocystis hominis cysts to metronidazole. Tropical Med Int Health: TM & IH 1(5):677–678CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Kok Hoe Chan
    • 1
  • Samudi Chandramathi
    • 2
  • Kumar Suresh
    • 2
    Email author
  • Kek Heng Chua
    • 1
  • Umah Rani Kuppusamy
    • 1
  1. 1.Department of Molecular Medicine, Faculty of MedicineUniversity of MalayaKuala LumpurMalaysia
  2. 2.Department of Parasitology, Faculty of MedicineUniversity of MalayaKuala LumpurMalaysia

Personalised recommendations